Related references
Note: Only part of the references are listed.Sevelamer carbonate in the treatment of hyperphosphatemia in patients with chronic kidney disease on hemodialysis
Vincenzo Savica
Therapeutics and Clinical Risk Management (2016)
The phosphorus pyramid: a visual tool for dietary phosphate management in dialysis and CKD patients
Claudia D'Alessandro et al.
BMC NEPHROLOGY (2015)
Role of NPT2b in health and chronic kidney disease
Yves Sabbagh et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2014)
Next-Generation Phosphate Binders: Focus on Iron-Based Binders
Dimitra Nastou et al.
DRUGS (2014)
Serum phosphorus levels and pill burden are inversely associated with adherence in patients on hemodialysis
Steven Wang et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
The effects of colestilan versus placebo and sevelamer in patients with CKD 5D and hyperphosphataemia: a 1-year prospective randomized study
Francesco Locatelli et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Vascular calcification in chronic kidney disease: are biomarkers useful for probing the pathobiology and the health risks of this process in the clinical scenario?
Sophie Liabeuf et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Is chronic kidney disease-mineral bone disorder (CKD-MBD) really a syndrome?
Mario Cozzolino et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Nutritional Therapy, Phosphate Control and Renal Protection
Juan Jesus Carrero et al.
NEPHRON CLINICAL PRACTICE (2014)
Magnesium Modifies the Cardiovascular Mortality Risk Associated with Hyperphosphatemia in Patients Undergoing Hemodialysis: A Cohort Study
Yusuke Sakaguchi et al.
PLOS ONE (2014)
Effect of chitosan chewing gum on reducing serum phosphorus in hemodialysis patients: a multi-center, randomized, double-blind, placebo-controlled trial
Tadao Akizawa et al.
BMC NEPHROLOGY (2014)
Niacin as a drug repositioning candidate for hyperphosphatemia management in dialysis patients
Sooyoung Shin et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2014)
Randomized Clinical Trial of the Iron-Based Phosphate Binder PA21 in Hemodialysis Patients
Rudolf P. Wuethrich et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis
Sophie A. Jamal et al.
LANCET (2013)
FGF23 antagonism: the thin line between adaptation and maladaptation in chronic kidney disease
Markus Ketteler et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
A comparison of calcium acetate/magnesium carbonate and sevelamer-hydrochloride effects on fibroblast growth factor-23 and bone markers: post hoc evaluation from a controlled, randomized study
Adrian Covic et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Hyperphosphatemia in patients with ESRD: assessing the current evidence linking outcomes with treatment adherence
Adrian Covic et al.
BMC NEPHROLOGY (2013)
Use of Nicotinamide to Treat Hyperphosphatemia in Dialysis Patients
Aurelie Lenglet et al.
DRUGS IN R&D (2013)
Impaired Response of FGF-23 to Oral Phosphate in Patients with Type 2 Diabetes: A Possible Mechanism of Atherosclerosis
Koichiro Yoda et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality
Victoria Shalhoub et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium diets
David M. Spiegel et al.
KIDNEY INTERNATIONAL (2012)
Clinical Efficacy and Cost-Effectiveness of Lanthanum Carbonate as Second-line Therapy in Hemodialysis Patients in Japan
Shunsuke Goto et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Homocysteine and folic acid levels in hemodialysis patients treated with sevelamer hydrochloride
S. Goto et al.
CLINICAL NEPHROLOGY (2011)
FGF23 induces left ventricular hypertrophy
Christian Faul et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Pharmacology, efficacy and safety of oral phosphate binders
Alastair J. Hutchison et al.
NATURE REVIEWS NEPHROLOGY (2011)
Dietary phosphate restriction in dialysis patients: A new approach for the treatment of hyperphosphataemia
B. Guida et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2011)
Cost-Effectiveness of Lanthanum Carbonate versus Sevelamer Hydrochloride for the Treatment of Hyperphosphatemia in Patients with End-Stage Renal Disease: A US Payer Perspective
Haesuk Park et al.
VALUE IN HEALTH (2011)
Phosphate Metabolism in CKD Stages 3-5: Dietary and Pharmacological Control
Markus Ketteler
INTERNATIONAL JOURNAL OF NEPHROLOGY (2011)
Increased parathyroid expression of klotho in uremic rats
Jacob Hofman-Bang et al.
KIDNEY INTERNATIONAL (2010)
Effect of MCI-196 on serum phosphate and cholesterol levels in haemodialysis patients with hyperphosphataemia: a double-blind, randomized, placebo-controlled study
Francesco Locatelli et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Niacin as potential treatment for dyslipidemia and hyperphosphatemia associated with chronic renal failure: the need for clinical trials
Mohamed H. Ahmed
RENAL FAILURE (2010)
The Ubiquitous Nature and Elusive Role of Phosphorus and Vascular Calcification
Jordi Goldstein-Fuchs et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Salivary Phosphorus Binding: A Novel Approach to Control Hyperphosphatemia
Garabed Eknoyan
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Salivary Phosphate-Binding Chewing Gum Reduces Hyperphosphatemia in Dialysis Patients
Vincenzo Savica et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
The emerging role of phosphate in vascular calcification
Cecilia M. Giachelli
KIDNEY INTERNATIONAL (2009)
Oral phosphate binders
Alastair J. Hutchison
KIDNEY INTERNATIONAL (2009)
Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease?
Christian S. Shinaberger et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2008)
Endotoxin-binding affinity of sevelamer hydrochloride
Mary C. Perianayagam et al.
AMERICAN JOURNAL OF NEPHROLOGY (2008)
Gadolinium and nephrogenic systemic fibrosis: The evidence of things not seen
Jonathan Kay
CLEVELAND CLINIC JOURNAL OF MEDICINE (2008)
Gadolinium and lanthanum: A iatrogenic transmetallation?
Simona Brambilla et al.
CLINICAL BIOCHEMISTRY (2008)
Efficacy and tolerability of sevelamer carbonate in hyperphosphatemic patients who have chronic kidney disease and are not on dialysis
Markus Ketteler et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Magnesium carbonate for phosphate control in patients on hemodialysis. A randomized controlled trial
Ioannis P. Tzanakis et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2008)
Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients
Anibal Ferreira et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Calcimimetics in chronic kidney disease: evidence, opportunities and challenges
Pieter Evenepoel
KIDNEY INTERNATIONAL (2008)
Switching to lanthanum carbonate monotherapy provides effective phosphate control with a low tablet burden
Alastair J. Hutchison et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Long-term efficacy and safety profile of lanthanum carbonate: Results for up to 6 years of treatment
Alastair J. Hutchison et al.
NEPHRON CLINICAL PRACTICE (2008)
A comparative review of the efficacy and safety of established phosphate binders: calcium, sevelamer, and lanthanum carbonate
Stuart M. Sprague
CURRENT MEDICAL RESEARCH AND OPINION (2007)
Intestinal phosphate absorption in a model of chronic renal failure
J. Marks et al.
KIDNEY INTERNATIONAL (2007)
The case against calcium-based phosphate binders
Sharon M. Moe et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Calcium-based phosphate binders are appropriate in chronic renal failure
Eli A. Friedman
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Phosphate binders: Hold the calcium?
David A. Bushinsky
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Extended release nicotinic acid - a novel oral agent for phosphate control
Krishnaswamy Sampathkumar et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2006)
Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis
GA Block et al.
KIDNEY INTERNATIONAL (2005)
Consequences and management of hyperphosphatemia in patients with renal insufficiency
EA Friedman
KIDNEY INTERNATIONAL (2005)
Nicotinamide suppresses hyperphosphatemia in hemodialysis patients
Y Takahashi et al.
KIDNEY INTERNATIONAL (2004)
PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect
S Tunaru et al.
NATURE MEDICINE (2003)
Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients
GM Chertow et al.
KIDNEY INTERNATIONAL (2002)
Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease - The ADMIT Study: A randomized trial
MB Elam et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
